Nicoya
Scientific instrumentation · Remote
Account Executive
Nov 2025 – Present
Own the full commercial portfolio for the Central U.S. across pharma, biotech, and academic R&D. Manage technical sales from scientific discovery and workflow evaluation through funding, procurement, and close.
- Achieved 111% of FY26 Q3, 115% of FY26 Q4, and 228% of FY27 Q1 targets.
- Grew territory pipeline 10×, from $500K to $5M+.
- Manage $400K+ opportunities and sales cycles extending beyond nine months across SPR, DSF, CD, HDX-MS, and stopped-flow.
- First AE to close a cross-platform CD and SPR instrument sale following Nicoya’s acquisition of Applied Photophysics.
Junior Account Executive
Jun 2025 – Nov 2025
Owned commercial growth for the OpenSPR portfolio across North America, working with academic, biotech, and pharmaceutical researchers.
- Rebuilt the OpenSPR pipeline to $1.465M in qualified opportunities.
- Achieved 156% of the FY26 Q2 on-ramp target ($156K against $100K).
- Created $3.4M in cross-sell pipeline through adjacent opportunities and collaboration with other AEs.
SDR Team Lead
Jun 2024 – Jun 2025
Led day-to-day SDR operations and outbound territory development across New England.
- Generated $6.3M in self-sourced pipeline and $1.4M in influenced revenue.
- Exceeded 125% of quota on instrument warranty sales.
- Hired and mentored four SDRs and developed onboarding and prospecting playbooks.
- Automated conference lead capture and enrichment in JavaScript, saving approximately 10 hours per event.
Senior Sales Development Representative
Jun 2023 – Jun 2024
Developed outbound opportunities for Nicoya’s SPR portfolio across pharma, biotech, and academic research in North America and EMEA.
- Ranked #1 at 113.6% of meeting quota; sourced $1.1M+ in influenced revenue and secured 40+ prospect meetings.
- Exceeded lead-generation targets by 50%+ at North American and EMEA industry conferences.



